Skip to search formSkip to main contentSkip to account menu

EM 574

Known as: EM-574, EM574 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Idremcinal

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
EM574, an erythromycin derivative, improves delayed gastric emptying of semi-solid meals in conscious dogs.
2000
2000
Corrigendum to: EM574, an erythromycin derivative, improves delayed gastric emptying of semi-solid meals in conscious dogs
1999
1999
Application of liquid chromatography-turbo ion spray tandem mass spectrometry for quantitative analysis of a potent motilin receptor agonist, EM574, and its metabolites in human plasma.
1999
1999
Effect of EM574 on Postprandial Pancreaticobiliary Secretion, Gastric Motor Activity, and Emptying in Conscious Dogs
EM574, an erythromycin derivative and a potentmotilin receptor agonist, is now under clinical trial asa gastroprokinetic drug… 
1997
1997
EM574, an erythromycin derivative, is a motilin receptor agonist in the rabbit.
1996
1996
Microbial conversion of EM574 and EM523, gastrointestinal motor stimulating agents.
EM574 exerts gastrointestinal motor stimulating (GMS) activity even after being converted to its metabolites P1 and P2 in dogs… 
1995
1995
[Erythromycin derivative EM574 with motilin agonistic effect on human gastric antrum].
1995
1995
Non-Ulcer Dyspepsia患者に対する消化管運動改善剤Motilide (EM574) の胃排出能に及ぼす影響
1994
1994
Bioactive metabolites of a motilide (EM574), gastrointestinal motor stimulators in in vivo therapy.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)